Yes i have asked the mods to delete my post...the 'fell over' bit was for another indication.
More accurate status for DMD is below:
The pharma giant also reported that ongoing discussions with the FDA have created a roadblock for their Phase III trial of a new gene therapy for Duchenne muscular dystrophy now dubbed fordadistrogene movaparvovec.
My view still stands - we won't see GT solution for DMD anytime soon.
FDA will make both Pfizer and Sarepta jump through some very expensive and time consuming hoops to prove GT safety and efficacy.
Sarepta, Roche and Pfizer need to look at a more practical solution as a bridge until GT is further refined...and safe.
Accumulate on weakness!
.
- Forums
- ASX - By Stock
- Pfizer hits brakes on DMD gene therapy
Yes i have asked the mods to delete my post...the 'fell over'...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
0.004(4.94%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.1¢ | 8.5¢ | 8.1¢ | $46.54K | 563.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 164616 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 100110 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 164616 | 0.081 |
3 | 143000 | 0.080 |
1 | 250000 | 0.079 |
3 | 71500 | 0.078 |
2 | 121300 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 100110 | 1 |
0.087 | 125000 | 1 |
0.089 | 102263 | 2 |
0.090 | 146175 | 1 |
0.091 | 108000 | 1 |
Last trade - 15.55pm 28/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online